By Joke Kujenya
A SPIKE in the new Human Metapneumovirus (HMPV) cases in northern China has raised public concerns, with hospitals reportedly overwhelmed and social media flooded with images of masked individuals in crowded waiting areas.
Across northern China this winter, particularly among children, and other countries, including India, Malaysia, and Kazakhstan, have also reported a rise in cases.
The respiratory virus, known to cause flu-like symptoms, poses higher risks for young children, the elderly, and those with compromised immune systems.
HMPV is not new to medical science, having been first identified in 2001, but its resurgence this winter has been notable.
Health authorities in China have attributed the rise to seasonal trends, with Foreign Ministry spokesperson Mao Ning stating, “Respiratory infections tend to peak during the winter season.”
She assured the public that this year’s outbreak appears less severe than the previous one.
Neighbouring countries like India, Malaysia, and Kazakhstan have also reported HMPV cases, prompting governments to monitor the situation closely.
In Cambodia, officials issued warnings about its potential to cause complications similar to influenza and COVID-19 in vulnerable groups.
Meanwhile, Taiwan’s Centers for Disease Control urged heightened vigilance, particularly for children and the elderly.
The United Kingdom has also seen a slight rise in HMPV infections.
According to the UK Health Security Agency’s weekly surveillance report, positivity rates reached 4.5%, with the highest rate of 10% observed in children under five.
The agency described the virus as part of the usual seasonal trend of respiratory illnesses but cautioned that current data should be viewed in light of reporting delays due to the holiday period.
Experts, however, have reassured the public that HMPV is unlikely to spread on a scale comparable to the COVID-19 pandemic.
Australian virologist Jill Carr explained that COVID-19’s initial rapid spread stemmed from a lack of immunity in humans, a factor not applicable to HMPV.
“This situation is very different,” she stated, adding that HMPV cases tend to follow established seasonal patterns.
Human metapneumovirus primarily spreads through respiratory droplets or contaminated surfaces, with symptoms ranging from mild cold-like conditions to severe complications such as pneumonia and bronchitis.
While no specific antiviral treatment or vaccine exists for the virus, supportive care remains the primary approach to managing infections.
Neighbouring India’s Directorate General of Health Services urged calm, describing HMPV as “like any other respiratory virus” causing flu-like symptoms in vulnerable populations.
Similarly, China’s government has assured residents and visitors that the country remains safe for travel.
Despite reassurances however, the growing number of cases worldwide has placed HMPV under the spotlight.
Public health agencies are closely monitoring developments as countries navigate the dual challenges of managing rising infections while dispelling unwarranted fears of another global health crisis.
